Literature DB >> 32482087

Incidence of New-Onset and Worsening Heart Failure Before and After the COVID-19 Epidemic Lockdown in Denmark: A Nationwide Cohort Study.

Charlotte Andersson1,2, Thomas Gerds3, Emil Fosbøl4, Matthew Phelps5, Julie Andersen5, Morten Lamberts2, Anders Holt2, Jawad H Butt4, Christian Madelaire2, Gunnar Gislason4,5, Christian Torp-Pedersen6,7, Lars Køber4, Morten Schou2.   

Abstract

BACKGROUND: The Danish government ordered a public lockdown on March 12, 2020, because of the coronavirus disease 2019 (COVID-19) pandemic. We investigated the immediate consequences of such a lockdown for patients with heart failure (HF).
METHODS: Using the Danish nationwide administrative databases, we investigated the incidence of new-onset HF and hospitalizations for worsening HF before and after the lockdown (January 1 to March 11 versus March 12 to March 31) in 2020 versus 2019. We also investigated the mortality for all patients with HF and in COVID-19-infected patients with HF.
RESULTS: Rates of new-onset HF between January 1 and March 11 were comparable for 2020 and 2019 (1.83 versus 1.78 per 10 000 person-years; P=0.19), while hospitalizations for worsening HF were slightly higher in 2020 versus 2019 (1.04 versus 0.93 per 1000 person-years; P=0.02). In the lockdown period, rates of new-onset HF diagnoses (1.26 versus 2.25 per 1000 person-years) and of hospitalizations for worsening HF (0.63 versus 0.99 per 1000 person-years) were significantly lower in 2020 versus 2019 (P for both, <0.0001). Mortality was similar before and after the national lockdown for the population with HF. We observed 90 HF patients with diagnosed COVID-19 infection, of whom 37% (95% CI, 23%-50%) died within 15 days.
CONCLUSIONS: The number of patients hospitalized with worsening HF or diagnosed with new-onset HF was markedly reduced after lockdown but has not yet impacted mortality in HF patients at a population-based level. However, these data raise concerns for a potential undertreatment of HF currently that may impact prognosis in the longer term.

Entities:  

Keywords:  heart failure; hospitalization; incidence; infections

Mesh:

Year:  2020        PMID: 32482087     DOI: 10.1161/CIRCHEARTFAILURE.120.007274

Source DB:  PubMed          Journal:  Circ Heart Fail        ISSN: 1941-3289            Impact factor:   8.790


  42 in total

1.  Non-COVID outcomes associated with the coronavirus disease-2019 (COVID-19) pandemic effects study (COPES): A systematic review and meta-analysis.

Authors:  Vincent Issac Lau; Sumeet Dhanoa; Harleen Cheema; Kimberley Lewis; Patrick Geeraert; David Lu; Benjamin Merrick; Aaron Vander Leek; Meghan Sebastianski; Brittany Kula; Dipayan Chaudhuri; Arnav Agarwal; Daniel J Niven; Kirsten M Fiest; Henry T Stelfox; Danny J Zuege; Oleksa G Rewa; Sean M Bagshaw
Journal:  PLoS One       Date:  2022-06-24       Impact factor: 3.752

2.  Hospitalization deficit of in- and outpatient cases with cardiovascular diseases and utilization of cardiological interventions during the COVID-19 pandemic: Insights from the German-wide helios hospital network.

Authors:  Sebastian König; Laura Ueberham; Vincent Pellissier; Sven Hohenstein; Andreas Meier-Hellmann; Holger Thiele; Vusal Ahmadli; Michael A Borger; Ralf Kuhlen; Gerhard Hindricks; Andreas Bollmann
Journal:  Clin Cardiol       Date:  2021-01-26       Impact factor: 3.287

3.  Practice Patterns and Patient Outcomes After Widespread Adoption of Remote Heart Failure Care.

Authors:  Neal Yuan; Patrick G Botting; Yaron Elad; Shaun J Miller; Susan Cheng; Joseph E Ebinger; Michelle M Kittleson
Journal:  Circ Heart Fail       Date:  2021-09-30       Impact factor: 10.447

4.  Thirty-Day Mortality and Morbidity in COVID-19 Positive vs. COVID-19 Negative Individuals and vs. Individuals Tested for Influenza A/B: A Population-Based Study.

Authors:  Vardan Nersesjan; Moshgan Amiri; Hanne K Christensen; Michael E Benros; Daniel Kondziella
Journal:  Front Med (Lausanne)       Date:  2020-11-30

5.  Recent trends in cardiovascular disease deaths: a state specific perspective.

Authors:  Sheila M Manemann; Yariv Gerber; Suzette J Bielinski; Alanna M Chamberlain; Karen L Margolis; Susan A Weston; Jill M Killian; Véronique L Roger
Journal:  BMC Public Health       Date:  2021-06-01       Impact factor: 3.295

Review 6.  Heart failure and COVID-19.

Authors:  Feras Bader; Yosef Manla; Bassam Atallah; Randall C Starling
Journal:  Heart Fail Rev       Date:  2021-01       Impact factor: 4.654

7.  Cardiovascular comorbidities as predictors for severe COVID-19 infection or death.

Authors:  Matthew Phelps; Daniel Mølager Christensen; Thomas Gerds; Emil Fosbøl; Christian Torp-Pedersen; Morten Schou; Lars Køber; Kristian Kragholm; Charlotte Andersson; Tor Biering-Sørensen; Helle Collatz Christensen; Mikkel Porsborg Andersen; Gunnar Gislason
Journal:  Eur Heart J Qual Care Clin Outcomes       Date:  2021-03-15

8.  Prognostic Impact of Prior Heart Failure in Patients Hospitalized With COVID-19.

Authors:  Jesus Alvarez-Garcia; Samuel Lee; Arjun Gupta; Matthew Cagliostro; Aditya A Joshi; Mercedes Rivas-Lasarte; Johanna Contreras; Sumeet S Mitter; Gina LaRocca; Pilar Tlachi; Danielle Brunjes; Benjamin S Glicksberg; Matthew A Levin; Girish Nadkarni; Zahi Fayad; Valentin Fuster; Donna Mancini; Anuradha Lala
Journal:  J Am Coll Cardiol       Date:  2020-10-28       Impact factor: 24.094

9.  National all-cause mortality during the COVID-19 pandemic: a Danish registry-based study.

Authors:  Elisabeth Helen Anna Mills; Amalie Lykkemark Møller; Filip Gnesin; Nertila Zylyftari; Marcella Broccia; Britta Jensen; Morten Schou; Emil L Fosbøl; Lars Køber; Mikkel Porsborg Andersen; Matthew Phelps; Thomas Gerds; Christian Torp-Pedersen
Journal:  Eur J Epidemiol       Date:  2020-09-21       Impact factor: 8.082

10.  Temporal trends in decompensated heart failure and outcomes during COVID-19: a multisite report from heart failure referral centres in London.

Authors:  Antonio Cannatà; Daniel I Bromage; Irfan A Rind; Caterina Gregorio; Clare Bannister; Mohammed Albarjas; Susan Piper; Ajay M Shah; Theresa A McDonagh
Journal:  Eur J Heart Fail       Date:  2020-09-28       Impact factor: 17.349

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.